Participants received 480 mg of nivolumab and 160 mg of relatlimab intravenously once every 4 weeks for two cycles before ...

The CUP-DIU study explored the relationship between IUD displacement and the use of a menstrual cup in 747 women who consulted for follow-up of their IUD at 2 primary care facilities in Paris.

The Food and Drug Administration (FDA) has accepted the New Drug Application for doravirine/islatravir (DOR/ISL) for adults with virologically-suppressed HIV-1 infection.

Penpulimab-kcqx, a humanized immunoglobulin G1 monoclonal antibody, blocks the interaction between the programmed death 1 receptor on T-cells and programmed death ligand 1 and 2 on tumor cells.

The FDA has approved Zegfrovy (sunvozertinib) for locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations.

Stay connected with Reverb by MPR News for news for and about young adults. Explore current topics and relevant perspectives. Click for more with MPR News.